Literature DB >> 20858854

Autocrine/paracrine cytokine stimulation of leukemic cell proliferation in smoldering and chronic adult T-cell leukemia.

Jing Chen1, Mike Petrus, Bonita R Bryant, Vinh Phuc Nguyen, Carolyn K Goldman, Richard Bamford, John C Morris, John E Janik, Thomas A Waldmann.   

Abstract

Adult T-cell leukemia (ATL), a heterogeneous disease, can be divided into smoldering, chronic, lymphoma, and acute types clinically. In addition to different clinical manifestations, different stages of ATL have different molecular signatures. Here, we demonstrated that smoldering/chronic ATL peripheral blood mononuclear cells spontaneously proliferated ex vivo in a cytokine (interleukin-12 [IL-12]/IL-9/IL-15)-dependent manner, while acute-type ATL peripheral blood mononuclear cells did not proliferate or proliferated independent of cytokines. Smoldering/chronic ATL cells produced IL-2 and IL-9 in 6-day ex vivo cultures. Interestingly, the addition of an anti-IL-2R-α monoclonal antibody profoundly inhibited IL-9 expression, suggesting optimal expression of IL-9 was dependent on IL-2 signaling in these patients. To determine whether there would be autonomous proliferation of ATL leukemic cells, we purified leukemic cells from patients with smoldering/chronic ATL. Purified leukemic cells cultured alone produced IL-2/IL-9, and the downstream Janus kinase/signal transducer and activator of transcription pathway was activated. However, the leukemic cells did not proliferate independently, but required coculture with autologous monocytes to induce proliferation. Moreover, interaction between leukemic cells and monocytes was contact dependent, and major histocompatibility complex class II expression may have contributed to this interaction. In conclusion, our data provide evidence that there is autocrine/paracrine cytokine stimulation of leukemic cell proliferation in patients with smoldering/chronic ATL that could be targeted for treatment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20858854      PMCID: PMC3031384          DOI: 10.1182/blood-2010-04-277418

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  37 in total

1.  Increasing methylation of the CDKN2A gene is associated with the progression of adult T-cell leukemia.

Authors:  K Nosaka; M Maeda; S Tamiya; T Sakai; H Mitsuya; M Matsuoka
Journal:  Cancer Res       Date:  2000-02-15       Impact factor: 12.701

2.  IL-15Ralpha recycles and presents IL-15 In trans to neighboring cells.

Authors:  Sigrid Dubois; Jennifer Mariner; Thomas A Waldmann; Yutaka Tagaya
Journal:  Immunity       Date:  2002-11       Impact factor: 31.745

3.  Flow cytometric analysis of cytokine receptor signal transduction.

Authors:  Subburaj Ilangumaran; Dina Finan; Robert Rottapel
Journal:  J Immunol Methods       Date:  2003-07       Impact factor: 2.303

Review 4.  Life, death, and tax: role of HTLV-I oncoprotein in genetic instability and cellular transformation.

Authors:  Kuan-Teh Jeang; Chou-zen Giam; Franca Majone; Mordechai Aboud
Journal:  J Biol Chem       Date:  2004-04-16       Impact factor: 5.157

5.  Gene silencing of the tyrosine phosphatase SHP1 gene by aberrant methylation in leukemias/lymphomas.

Authors:  Takashi Oka; Mamoru Ouchida; Maho Koyama; Yoichiro Ogama; Shinichi Takada; Yoko Nakatani; Takehiro Tanaka; Tadashi Yoshino; Kazuhiko Hayashi; Nobuya Ohara; Eisaku Kondo; Kiyoshi Takahashi; Junjiro Tsuchiyama; Mitsune Tanimoto; Kenji Shimizu; Tadaatsu Akagi
Journal:  Cancer Res       Date:  2002-11-15       Impact factor: 12.701

6.  IL-2- and STAT5-regulated cytokine gene expression in cells expressing the Tax protein of HTLV-1.

Authors:  Michelle M Fung; Yen-Lin Chu; J Lynn Fink; Anne Wallace; Kathleen L McGuire
Journal:  Oncogene       Date:  2005-07-07       Impact factor: 9.867

7.  T-cell growth factor gene: lack of expression in human T-cell leukemia-lymphoma virus-infected cells.

Authors:  S K Arya; F Wong-Staal; R C Gallo
Journal:  Science       Date:  1984-03-09       Impact factor: 47.728

8.  Heterogeneity in response to interleukin 2 and interleukin 2-producing ability of adult T cell leukemic cells.

Authors:  N Arima; Y Daitoku; Y Yamamoto; K Fujimoto; S Ohgaki; K Kojima; J Fukumori; K Matsushita; H Tanaka; K Onoue
Journal:  J Immunol       Date:  1987-05-01       Impact factor: 5.422

9.  Evidence for the interleukin-2 dependent expansion of leukemic cells in adult T cell leukemia.

Authors:  M Maeda; N Arima; Y Daitoku; M Kashihara; H Okamoto; T Uchiyama; K Shirono; M Matsuoka; T Hattori; K Takatsuki
Journal:  Blood       Date:  1987-11       Impact factor: 22.113

10.  Surface phenotype of Japanese adult T-cell leukemia cells characterized by monoclonal antibodies.

Authors:  T Hattori; T Uchiyama; T Toibana; K Takatsuki; H Uchino
Journal:  Blood       Date:  1981-09       Impact factor: 22.113

View more
  20 in total

1.  Safety, efficacy, and pharmacokinetics/pharmacodynamics of daclizumab (anti-CD25) in patients with adult T-cell leukemia/lymphoma.

Authors:  Jonathan L Berkowitz; John E Janik; Donn M Stewart; Elaine S Jaffe; Maryalice Stetler-Stevenson; Joanna H Shih; Thomas A Fleisher; Maria Turner; Nicole E Urquhart; Gilian H Wharfe; William D Figg; Cody J Peer; Carolyn K Goldman; Thomas A Waldmann; John C Morris
Journal:  Clin Immunol       Date:  2014-09-28       Impact factor: 3.969

Review 2.  Disorders of the JAK/STAT Pathway in T Cell Lymphoma Pathogenesis: Implications for Immunotherapy.

Authors:  Thomas A Waldmann; Jing Chen
Journal:  Annu Rev Immunol       Date:  2017-02-09       Impact factor: 28.527

Review 3.  JAK/STAT pathway directed therapy of T-cell leukemia/lymphoma: Inspired by functional and structural genomics.

Authors:  Thomas A Waldmann
Journal:  Mol Cell Endocrinol       Date:  2017-02-15       Impact factor: 4.102

4.  Selective targeting of JAK/STAT signaling is potentiated by Bcl-xL blockade in IL-2-dependent adult T-cell leukemia.

Authors:  Meili Zhang; Lesley A Mathews Griner; Wei Ju; Damien Y Duveau; Rajarshi Guha; Michael N Petrus; Bernard Wen; Michiyuki Maeda; Paul Shinn; Marc Ferrer; Kevin D Conlon; Richard N Bamford; John J O'Shea; Craig J Thomas; Thomas A Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-22       Impact factor: 11.205

5.  Platelet-derived growth factor alpha mediates the proliferation of peripheral T-cell lymphoma cells via an autocrine regulatory pathway.

Authors:  P P Piccaluga; M Rossi; C Agostinelli; F Ricci; A Gazzola; S Righi; F Fuligni; M A Laginestra; M Mancini; M R Sapienza; A De Renzo; P L Tazzari; D Gibellini; P Went; F Alviano; P L Zinzani; G P Bagnara; G Inghirami; C Tripodo; S A Pileri
Journal:  Leukemia       Date:  2014-01-31       Impact factor: 11.528

Review 6.  The dichotomous function of interleukin-9 in cancer diseases.

Authors:  K Gerlach; B Weigmann
Journal:  J Mol Med (Berl)       Date:  2019-08-08       Impact factor: 4.599

7.  Cytokine receptor signaling is required for the survival of ALK- anaplastic large cell lymphoma, even in the presence of JAK1/STAT3 mutations.

Authors:  Jing Chen; Yong Zhang; Michael N Petrus; Wenming Xiao; Alina Nicolae; Mark Raffeld; Stefania Pittaluga; Richard N Bamford; Masao Nakagawa; Sunny Tianyi Ouyang; Alan L Epstein; Marshall E Kadin; Annarose Del Mistro; Richard Woessner; Elaine S Jaffe; Thomas A Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-29       Impact factor: 11.205

8.  CP-690,550, a therapeutic agent, inhibits cytokine-mediated Jak3 activation and proliferation of T cells from patients with ATL and HAM/TSP.

Authors:  Wei Ju; Meili Zhang; Jian-kang Jiang; Craig J Thomas; Unsong Oh; Bonita R Bryant; Jing Chen; Noriko Sato; Yutaka Tagaya; John C Morris; John E Janik; Steven Jacobson; Thomas A Waldmann
Journal:  Blood       Date:  2010-11-24       Impact factor: 22.113

9.  Phase 1 trial of IL-15 trans presentation blockade using humanized Mikβ1 mAb in patients with T-cell large granular lymphocytic leukemia.

Authors:  Thomas A Waldmann; Kevin C Conlon; Donn M Stewart; TatYana A Worthy; John E Janik; Thomas A Fleisher; Paul S Albert; William D Figg; Shawn D Spencer; Mark Raffeld; Jean R Decker; Carolyn K Goldman; Bonita R Bryant; Michael N Petrus; Stephen P Creekmore; John C Morris
Journal:  Blood       Date:  2012-12-03       Impact factor: 22.113

Review 10.  A three-signal model of T-cell lymphoma pathogenesis.

Authors:  Ryan A Wilcox
Journal:  Am J Hematol       Date:  2015-11-17       Impact factor: 10.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.